🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

In this NEW article, Latika and colleagues explore the untapped potential of #Instagram to facilitate #rheumatology academia. 👉rdcu.be/czEAZ

Good morning. 🔥Hot off the press🔥 journals.sagepub.com/doi/10.1177/14… Please read our compelling, evidence based narrative to support low dose- methotrexate (LD-MTX). Time to consider LD-MTX as a new, separate and reinvented drug?!

RA-ILD affects 21.4% of RA patients globally, per an MA of 14,281 cases. Risk factors: smoking, DMARD use, low-income settings. Africa has the highest prevalence (38.2%) and Europe has the lowest (10.2%). Screening efforts are critical! #Rheumatology #ILD doi.org/10.1007/s00296…

🔬 Breakthrough or Bust? Biomarkers in hand OA hold promise, but none are ready for prime time. What’s missing, and what’s next? 🚀 Learn through our 🌶️review. #Osteoarthritis #Biomarkers #Rheumatology link.springer.com/10.1007/s00296…

Cross-sectional study of 50 SLE patients, 24% had fibromyalgianess, and 18% experienced widespread pain. Fibromyalgianess in SLE patients primarily reflects heightened pain sensitivity and symptom severity rather than SLE disease activity. buff.ly/4jzNxQG

📄Fulltext link to our review with Rosina Moralijska is available! 🫳Hand OA affects millions, yet no biomarker has made it to routine care. Can AI, multi-omics & novel tech finally change this? 🤖🔬 Hope is on the horizon! Learn through our 🌶️review. rdcu.be/d7ZD0

🚨 Association of muscle strength and cardiorespiratory fitness with all-cause and cancer-specific mortality in patients diagnosed with cancer 💪 ❤️ NEW systematic review with meta-analysis 📄 with the #TakeHomeMessages👇 #FREE ➡️ bit.ly/4hajayG

Meet Rheumavision Semi-Finalist Stoimen Dimitrov and his presentation 'axSpA and auto-inflammatory syndromes' 👏👏👏 Full version: pulse.ly/2kzuv7ouvl Please don't forget to show your support by likes and comments!!! All the luck for the finals Stoimen 🤞🤞🤞

#ShortFactSaturday💡 BD vs SLE– Ulcers in both but different stories ! 🔹Behçet’s Disease→ Oral ulcers is a Symptom 🔹 SLE → Oral ulcers is a Sign #Rheumtwitter #medtwitter

Do children of anti-Ro+ mothers face higher risks of allergies, neurodevelopmental, or autoimmune diseases? A large study says no significant difference! 🔍 #Rheumatology #NeonatalLupus doi.org/10.1002/acr.25…

Subtypes of cutaneous lupus Acute cutaneous #lupus most associated with #SLE Subacute lupus typically symmetrical, sun distributed areas can be 🔀 with Ro Abs Discoid most common subtype, scars! disseminated form esp neck ⬆️ SLE Tumidus ❌ scarring, urticaria skin #Rheumatology

⚖️ Weight loss is key in #osteoarthritis, but is it always beneficial? Our review dives into the risks—muscle loss, joint instability, and mental health impact. A balanced strategy is crucial! Read more in our latest review: mjrheum.org/current-issue/… #WeightLoss #Rheumatology

Statistical Data Editing in Scientific Articles pubmed.ncbi.nlm.nih.gov/28581261/

Just out! 📢 In our real-world RA cohort, comorbidities matter: diabetes & smoking significantly reduced sustained response. Time to think more personally about RA care. doi.org/10.5114/reum/1… 🧬 #Rheumatology #RA #bDMARDs #RealWorldEvidence #PrecisionMedicine

🧡 Today is #WorldASDay2025! We raise awareness of #AxSpA and daily challenges it brings. 🎗️Lace Up for axSpA – even tying shoelaces can be tough. Reumatologia joins the campaign and invites you to read our published articles on axSpA 👉reu.termedia.pl/Search/?s=spon…

1/🚨 Hot off the press! The 2024 #ACR guideline on #lupus #nephritis (LN) is here. A major update with new insights on diagnosis, treatment, monitoring, and patient-centered care. Here's what you need to know 🧵⬇️

Atrial fibrillation and stroke

10-20% of IBD pts have IBD-assoc. spondyloarthritis, as either peripheral arthritis or axial Dz, subclinical gut inflammation w/ IL-23–IL-17–TNFα playing central roles. TNFi & JAKi Rx is effective, but IL-17i may exacerbate IBD (vedolizumab??) Review here>>

Drugs associated with ANCA positivity.

🎉 Proud of our latest work! 9+ years of real-world RA data showed that long-term b/tsDMARD therapy is linked to low mortality (13.5/1000 PY) and high survival (87%). Beware: GCs and functional decline still kill. 🔗doi.org/10.3390/antib1… #Rheumatology #RAresearch #biologics